|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on february 11, 2019. upon further investigation of the reported event, the following information is new and/or changed: d1 (suspected medical device - updated brand name).D4 (additional device information - updated model number, unique identifier (udi) number and added exp date).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to correction and additional information).H4 (device manufacture date).H6 (identification of evaluation codes 11, 3331, 4114, 3259, 4307).Method code #1: 11 - testing of device from same lot/batch retained by manufacturer.Method code #2: 3331 - analysis of production records.Method code #3: 4114 - device not returned.Results code: 3259 - improper physical structure.Conclusions code: 4307 - cause traced to component failure.The sample was not returned; therefore, a complete investigation could not be performed, however, video provided with the complaint was reviewed.A retention sample from the same product code and lot number was inspected and found to still have the blue cap attached.The most likely root cause of the blue cap falling off is due to handling, post shipping, after the tcvs manufacturing process.All reservoirs are 100% visually inspected at several points in the production process.It is likely that the cap fell off due to a shock force at some point during the handling of the product; however, when or how this shock force was applied was not able to be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|